Delivery Order SPE2DB24D9313-SPE2DB25FFFHV
Award Date
2/18/25
Potential Completion Date
3/11/25
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,207.70 contract is for the delivery of MIRENA 52 MG SYSTEMS, a pharmaceutical product, with a period of performance through January 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,041.56 contract is for the delivery of MIRENA 52 MG SYSTEMS, a specialized pharmaceutical product, with a period of performance through March 11, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract has a ceiling value of $15,623.10 and a period of performance through February 4, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $5,207.70 and covers the delivery of Mirena 52 mg systems, a specialized pharmaceutical product, with a completion date of March 6, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $1,041.56, is for the delivery of the drug Mirena, a 52 mg intrauterine system. The contract has an ultimate completion date of February 12, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,920.00, is for the delivery of the pharmaceutical product Mirena 52 mg Systems. The contract has an ultimate completion date of December 19, 2024. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,207.70 contract is for the delivery of Mirena 52 mg systems, a contraceptive product, with a completion date of February 6, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide...
This is a firm fixed-price delivery order (SPE2DB20D9226|SPE2DB25FQ57E) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of Mirena 52 mg contraceptive systems. The $5,207.70 contract has an ultimate completion date of January 24, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs,...
This is a firm fixed-price delivery order (SPE2DB20D9759|SPE2DB25FD5JS) awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract, valued at $5,920.00, is for the delivery of Mirena 52 mg Systems, a contraceptive device, with a completion date of December 26, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription...
This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Mirena 52 mg systems to the Defense Logistics Agency (DLA). The award is a firm fixed-price contract with a ceiling value of $5,207.70 and a performance period ending January 22, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics, and...